Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study
Top Cited Papers
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 355 (9212) , 1303-1309
- https://doi.org/10.1016/s0140-6736(00)02111-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Aprotinin in liver transplantationHepatology, 1998
- Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantationLiver Transplantation and Surgery, 1997
- The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical studyHepatology, 1997
- A surgeon's perspective on the management of coagulation disorders before liver transplantationLiver Transplantation and Surgery, 1997
- Aprotinin for coronary artery bypass grafting: Effect on postoperative renal functionThe Annals of Thoracic Surgery, 1995
- PROTEASE ACTIVITIES, AS WELL AS PLASMINOGEN ACTIVATORS, CONTRIBUTE TO THE “LYTIC” STATE DURING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1993
- Influence of High-Dose Aprotinin on Hemostasis and Blood Requirement in Orthotopic Liver TransplantationSeminars in Thrombosis and Hemostasis, 1993
- Does aprotinin affect blood loss in liver transplantation?The Lancet, 1992
- POSSIBLE ROLE OF EXTRACELLULARLY RELEASED PHAGOCYTE PROTEINASES IN COAGULATION DISORDER DURING LIVER TRANSPLANTATIONTransplantation, 1991
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985